#$%^&*AU2012202065A120120503.pdf#####ABSTRACT: A genus of erythropoietin (Epo) receptor agonists having unique structural, biochemical, and physiological characteristics has been discovered and is referred to herein as Erythropoietin Receptor Extended Duration Limited Agonists (EREDLA).